Promotion Biologie, Biochemie - Molekulare Medizin (m/w/d)

With more than 20,000 students, University of Regensburg is an innovative and interdisciplinary campus university with diverse research activities and a broad range of courses for young people from Germany and abroad. At the Chair of Experimental Medicine and Therapy Research ( https://www.experimentelle-medizin.de/ ) in the research group Immunobiology of early systemic cancer, a position is available for a PhD Candidate (m/f/d) starting on January 1, 2025.

This temporary employment is for the purpose of academic qualification (doctorate) with a contract duration of 3 years (§2 Abs. 1 WissZeitVG). Employment and salary for the offered position will be based upon the collective regulations defined for the German public service sector (TV-L). We are seeking a dedicated researcher with a strong interest in the immunobiology of early systemic cancer for a project funded by the German Research Foundation (DFG). In this role, you will study immune and organ defense mechanisms in early metastasis, focusing on melanoma and breast cancer.

Leveraging patient samples, advanced patient-derived models and single-cell omics technologies, you will investigate the early interactions between cancer cells and metastatic niches in the bone marrow and lymph nodes. Your research will focus on how cancer cells evade immune suppression and niche-specific defenses. By analyzing these mechanisms, you will contribute to identifying therapeutic targets that extend clinical latency and restore the body's natural defense against metastasis.
a Master's degree (or equivalent) in biology, biochemistry, biomedicine, or a closely related field
a profound interest in the (immuno-) biology of cancer and metastasis
a creative mindset combined with a highly organized and precise way to conduct experiments
a passion for discovering the unknown, paired with a resilient and persistent personality
enthusiasm for learning and developing new technologies
the ability to work both independently and as well as collaboratively in a multidisciplinary and international team
hands-on expertise with basic cellular, immunological and molecular techniques
excellent oral and written communication and presentation skills

an opportunity to work at the interface of immunology and cancer, one of the most exciting and rapidly advancing areas biomedical research
to become part of an internationally acknowledged research group on cancer metastasis
a motivating and dynamic working environment with flat hierarchies
access to a well-structured, interdisciplinary PhD program within the framework of the local graduate schools (RIGeL, BioMediGS)
a fixed-term contract for a period of 3 years with direct supervision by experienced scientists
the University of Regensburg is particularly committed to support the reconciliation of work and family life. For more information please refer to https://www.uni-regensburg.de/equal-opportunities/chancengleichheit/startseite/index.html.

With more than 20,000 students, University of Regensburg is an innovative and interdisciplinary campus university with diverse research activities and a broad range of courses for young people from Germany and abroad. At the Chair of Experimental Medicine and Therapy Research ( https://www.experimentelle-medizin.de/ ) in the research group Immunobiology of early systemic cancer, a position is available for a PhD Candidate (m/f/d) starting on January 1, 2025.

This temporary employment is for the purpose of academic qualification (doctorate) with a contract duration of 3 years (§2 Abs. 1 WissZeitVG). Employment and salary for the offered position will be based upon the collective regulations defined for the German public service sector (TV-L). We are seeking a dedicated researcher with a strong interest in the immunobiology of early systemic cancer for a project funded by the German Research Foundation (DFG). In this role, you will study immune and organ defense mechanisms in early metastasis, focusing on melanoma and breast cancer.

Leveraging patient samples, advanced patient-derived models and single-cell omics technologies, you will investigate the early interactions between cancer cells and metastatic niches in the bone marrow and lymph nodes. Your research will focus on how cancer cells evade immune suppression and niche-specific defenses. By analyzing these mechanisms, you will contribute to identifying therapeutic targets that extend clinical latency and restore the body's natural defense against metastasis.
a Master's degree (or equivalent) in biology, biochemistry, biomedicine, or a closely related field
a profound interest in the (immuno-) biology of cancer and metastasis
a creative mindset combined with a highly organized and precise way to conduct experiments
a passion for discovering the unknown, paired with a resilient and persistent personality
enthusiasm for learning and developing new technologies
the ability to work both independently and as well as collaboratively in a multidisciplinary and international team
hands-on expertise with basic cellular, immunological and molecular techniques
excellent oral and written communication and presentation skills

an opportunity to work at the interface of immunology and cancer, one of the most exciting and rapidly advancing areas biomedical research
to become part of an internationally acknowledged research group on cancer metastasis
a motivating and dynamic working environment with flat hierarchies
access to a well-structured, interdisciplinary PhD program within the framework of the local graduate schools (RIGeL, BioMediGS)
a fixed-term contract for a period of 3 years with direct supervision by experienced scientists
the University of Regensburg is particularly committed to support the reconciliation of work and family life. For more information please refer to https://www.uni-regensburg.de/equal-opportunities/chancengleichheit/startseite/index.html.

With more than 20,000 students, University of Regensburg is an innovative and interdisciplinary campus university with diverse research activities and a broad range of courses for young people from Germany and abroad. At the Chair of Experimental Medicine and Therapy Research ( https://www.experimentelle-medizin.de/ ) in the research group Immunobiology of early systemic cancer, a position is available for a PhD Candidate (m/f/d) starting on January 1, 2025.

This temporary employment is for the purpose of academic qualification (doctorate) with a contract duration of 3 years (§2 Abs. 1 WissZeitVG). Employment and salary for the offered position will be based upon the collective regulations defined for the German public service sector (TV-L). We are seeking a dedicated researcher with a strong interest in the immunobiology of early systemic cancer for a project funded by the German Research Foundation (DFG). In this role, you will study immune and organ defense mechanisms in early metastasis, focusing on melanoma and breast cancer.

Leveraging patient samples, advanced patient-derived models and single-cell omics technologies, you will investigate the early interactions between cancer cells and metastatic niches in the bone marrow and lymph nodes. Your research will focus on how cancer cells evade immune suppression and niche-specific defenses. By analyzing these mechanisms, you will contribute to identifying therapeutic targets that extend clinical latency and restore the body's natural defense against metastasis.
a Master's degree (or equivalent) in biology, biochemistry, biomedicine, or a closely related field
a profound interest in the (immuno-) biology of cancer and metastasis
a creative mindset combined with a highly organized and precise way to conduct experiments
a passion for discovering the unknown, paired with a resilient and persistent personality
enthusiasm for learning and developing new technologies
the ability to work both independently and as well as collaboratively in a multidisciplinary and international team
hands-on expertise with basic cellular, immunological and molecular techniques
excellent oral and written communication and presentation skills

an opportunity to work at the interface of immunology and cancer, one of the most exciting and rapidly advancing areas biomedical research
to become part of an internationally acknowledged research group on cancer metastasis
a motivating and dynamic working environment with flat hierarchies
access to a well-structured, interdisciplinary PhD program within the framework of the local graduate schools (RIGeL, BioMediGS)
a fixed-term contract for a period of 3 years with direct supervision by experienced scientists
the University of Regensburg is particularly committed to support the reconciliation of work and family life. For more information please refer to https://www.uni-regensburg.de/equal-opportunities/chancengleichheit/startseite/index.html.

With more than 20,000 students, University of Regensburg is an innovative and interdisciplinary campus university with diverse research activities and a broad range of courses for young people from Germany and abroad. At the Chair of Experimental Medicine and Therapy Research ( https://www.experimentelle-medizin.de/ ) in the research group Immunobiology of early systemic cancer, a position is available for a PhD Candidate (m/f/d) starting on January 1, 2025.

This temporary employment is for the purpose of academic qualification (doctorate) with a contract duration of 3 years (§2 Abs. 1 WissZeitVG). Employment and salary for the offered position will be based upon the collective regulations defined for the German public service sector (TV-L). We are seeking a dedicated researcher with a strong interest in the immunobiology of early systemic cancer for a project funded by the German Research Foundation (DFG). In this role, you will study immune and organ defense mechanisms in early metastasis, focusing on melanoma and breast cancer.

Leveraging patient samples, advanced patient-derived models and single-cell omics technologies, you will investigate the early interactions between cancer cells and metastatic niches in the bone marrow and lymph nodes. Your research will focus on how cancer cells evade immune suppression and niche-specific defenses. By analyzing these mechanisms, you will contribute to identifying therapeutic targets that extend clinical latency and restore the body's natural defense against metastasis.
a Master's degree (or equivalent) in biology, biochemistry, biomedicine, or a closely related field
a profound interest in the (immuno-) biology of cancer and metastasis
a creative mindset combined with a highly organized and precise way to conduct experiments
a passion for discovering the unknown, paired with a resilient and persistent personality
enthusiasm for learning and developing new technologies
the ability to work both independently and as well as collaboratively in a multidisciplinary and international team
hands-on expertise with basic cellular, immunological and molecular techniques
excellent oral and written communication and presentation skills

an opportunity to work at the interface of immunology and cancer, one of the most exciting and rapidly advancing areas biomedical research
to become part of an internationally acknowledged research group on cancer metastasis
a motivating and dynamic working environment with flat hierarchies
access to a well-structured, interdisciplinary PhD program within the framework of the local graduate schools (RIGeL, BioMediGS)
a fixed-term contract for a period of 3 years with direct supervision by experienced scientists
the University of Regensburg is particularly committed to support the reconciliation of work and family life. For more information please refer to https://www.uni-regensburg.de/equal-opportunities/chancengleichheit/startseite/index.html.

Produktmanager (m/w/d): Naturwissenschaftler, Mediziner, Bio-/Molekulare Mediziner als Experte für relevante Märkte, Trends und Meinungen im Bereich Healthcare gesucht.

lifespin ist ein interdisziplinäres, global aktives Healthcare-Unternehmen, das NMR, Metabolomik und KI kombiniert, um ein neues Paradigma der Gesundheitsversorgung zu ermöglichen. Unsere KI gesteuerte Metabolomik-Plattform bietet einen skalierbaren und erschwinglichen Weg zur Präzisionsmedizin. Unser Deep-Health-Ansatz ermöglicht es, die globale, moderne Gesundheitsversorgung voranzutreiben, indem digitale Zwillinge von Blutproben erstellt werden und im Kontext von Millionen anderer Profile proaktive, präzise und kontinuierliche Einblicke in die Gesundheit liefern.
Du bist Teil unseres Produktmanagement-Teams und wirst Experte für die relevanten Märkte, Trends, Meinungen und bringst diese proaktiv in unsere Strategie und unseren Entwicklungsprozess ein.
Du identifizierst und interagierst mit KOLs und baust somit ein nachhaltiges Netzwerk auf.
Du repräsentierst uns auf öffentlichen Foren und nutzt diese intensiv als Informationsquelle.
Du bist aber auch intensiv involviert, nicht nur beratend, in unsere Produktentwicklung,
vom Design, übers Risikomanagement, Usability, bis zur Eigenschaft als Product Owner.
Auch Nebenaufgaben, Start-up typisch schrecken Dich nicht ab. Du unterstützt uns z.B. im Marketing und bei der inhaltlichen Betreuung unserer Homepage und Social Media Profile.

Erfahrung im Bereich des strategischen Produktmanagements, Key Account- und Projektmanagements
Du hast hohes Durchsetzungsvermögen, hohe Eigenmotivation und-organisation, Belastbarkeit, und Integrität gegenüber dem Unternehmen.
Du hast Geschick und Stil im Umgang mit Kunden, Key Accounts und Kollegen.
Du hast Projektmanagement-/ Präsentationsfähigkeiten, sowie abgesicherte IT-Kenntnisse.
Du hast fundierte Sprachkenntnisse in Deutsch und Englisch.
Du hast ein abgeschlossenes naturwissenschaftliches oder medizinisches Studium, idealerweise mit Promotion

With more than 20,000 students, University of Regensburg is an innovative and interdisciplinary campus university with diverse research activities and a broad range of courses for young people from Germany and abroad. At the Chair of Experimental Medicine and Therapy Research ( https://www.experimentelle-medizin.de/ ) in the research group Immunobiology of early systemic cancer, a position is available for a PhD Candidate (m/f/d) starting on January 1, 2025.

This temporary employment is for the purpose of academic qualification (doctorate) with a contract duration of 3 years (§2 Abs. 1 WissZeitVG). Employment and salary for the offered position will be based upon the collective regulations defined for the German public service sector (TV-L). We are seeking a dedicated researcher with a strong interest in the immunobiology of early systemic cancer for a project funded by the German Research Foundation (DFG). In this role, you will study immune and organ defense mechanisms in early metastasis, focusing on melanoma and breast cancer.

Leveraging patient samples, advanced patient-derived models and single-cell omics technologies, you will investigate the early interactions between cancer cells and metastatic niches in the bone marrow and lymph nodes. Your research will focus on how cancer cells evade immune suppression and niche-specific defenses. By analyzing these mechanisms, you will contribute to identifying therapeutic targets that extend clinical latency and restore the body's natural defense against metastasis.
a Master's degree (or equivalent) in biology, biochemistry, biomedicine, or a closely related field
a profound interest in the (immuno-) biology of cancer and metastasis
a creative mindset combined with a highly organized and precise way to conduct experiments
a passion for discovering the unknown, paired with a resilient and persistent personality
enthusiasm for learning and developing new technologies
the ability to work both independently and as well as collaboratively in a multidisciplinary and international team
hands-on expertise with basic cellular, immunological and molecular techniques
excellent oral and written communication and presentation skills

an opportunity to work at the interface of immunology and cancer, one of the most exciting and rapidly advancing areas biomedical research
to become part of an internationally acknowledged research group on cancer metastasis
a motivating and dynamic working environment with flat hierarchies
access to a well-structured, interdisciplinary PhD program within the framework of the local graduate schools (RIGeL, BioMediGS)
a fixed-term contract for a period of 3 years with direct supervision by experienced scientists
the University of Regensburg is particularly committed to support the reconciliation of work and family life. For more information please refer to https://www.uni-regensburg.de/equal-opportunities/chancengleichheit/startseite/index.html.

Produktmanager (m/w/d): Naturwissenschaftler, Mediziner, Bio-/Molekulare Mediziner als Experte für relevante Märkte, Trends und Meinungen im Bereich Healthcare gesucht.

lifespin ist ein interdisziplinäres, global aktives Healthcare-Unternehmen, das NMR, Metabolomik und KI kombiniert, um ein neues Paradigma der Gesundheitsversorgung zu ermöglichen. Unsere KI gesteuerte Metabolomik-Plattform bietet einen skalierbaren und erschwinglichen Weg zur Präzisionsmedizin. Unser Deep-Health-Ansatz ermöglicht es, die globale, moderne Gesundheitsversorgung voranzutreiben, indem digitale Zwillinge von Blutproben erstellt werden und im Kontext von Millionen anderer Profile proaktive, präzise und kontinuierliche Einblicke in die Gesundheit liefern.
Du bist Teil unseres Produktmanagement-Teams und wirst Experte für die relevanten Märkte, Trends, Meinungen und bringst diese proaktiv in unsere Strategie und unseren Entwicklungsprozess ein.
Du identifizierst und interagierst mit KOLs und baust somit ein nachhaltiges Netzwerk auf.
Du repräsentierst uns auf öffentlichen Foren und nutzt diese intensiv als Informationsquelle.
Du bist aber auch intensiv involviert, nicht nur beratend, in unsere Produktentwicklung,
vom Design, übers Risikomanagement, Usability, bis zur Eigenschaft als Product Owner.
Auch Nebenaufgaben, Start-up typisch schrecken Dich nicht ab. Du unterstützt uns z.B. im Marketing und bei der inhaltlichen Betreuung unserer Homepage und Social Media Profile.

Erfahrung im Bereich des strategischen Produktmanagements, Key Account- und Projektmanagements
Du hast hohes Durchsetzungsvermögen, hohe Eigenmotivation und-organisation, Belastbarkeit, und Integrität gegenüber dem Unternehmen.
Du hast Geschick und Stil im Umgang mit Kunden, Key Accounts und Kollegen.
Du hast Projektmanagement-/ Präsentationsfähigkeiten, sowie abgesicherte IT-Kenntnisse.
Du hast fundierte Sprachkenntnisse in Deutsch und Englisch.
Du hast ein abgeschlossenes naturwissenschaftliches oder medizinisches Studium, idealerweise mit Promotion

With more than 20,000 students, University of Regensburg is an innovative and interdisciplinary campus university with diverse research activities and a broad range of courses for young people from Germany and abroad. At the Chair of Experimental Medicine and Therapy Research ( https://www.experimentelle-medizin.de/ ) in the research group Immunobiology of early systemic cancer, a position is available for a PhD Candidate (m/f/d) starting on January 1, 2025.

This temporary employment is for the purpose of academic qualification (doctorate) with a contract duration of 3 years (§2 Abs. 1 WissZeitVG). Employment and salary for the offered position will be based upon the collective regulations defined for the German public service sector (TV-L). We are seeking a dedicated researcher with a strong interest in the immunobiology of early systemic cancer for a project funded by the German Research Foundation (DFG). In this role, you will study immune and organ defense mechanisms in early metastasis, focusing on melanoma and breast cancer.

Leveraging patient samples, advanced patient-derived models and single-cell omics technologies, you will investigate the early interactions between cancer cells and metastatic niches in the bone marrow and lymph nodes. Your research will focus on how cancer cells evade immune suppression and niche-specific defenses. By analyzing these mechanisms, you will contribute to identifying therapeutic targets that extend clinical latency and restore the body's natural defense against metastasis.
a Master's degree (or equivalent) in biology, biochemistry, biomedicine, or a closely related field
a profound interest in the (immuno-) biology of cancer and metastasis
a creative mindset combined with a highly organized and precise way to conduct experiments
a passion for discovering the unknown, paired with a resilient and persistent personality
enthusiasm for learning and developing new technologies
the ability to work both independently and as well as collaboratively in a multidisciplinary and international team
hands-on expertise with basic cellular, immunological and molecular techniques
excellent oral and written communication and presentation skills

an opportunity to work at the interface of immunology and cancer, one of the most exciting and rapidly advancing areas biomedical research
to become part of an internationally acknowledged research group on cancer metastasis
a motivating and dynamic working environment with flat hierarchies
access to a well-structured, interdisciplinary PhD program within the framework of the local graduate schools (RIGeL, BioMediGS)
a fixed-term contract for a period of 3 years with direct supervision by experienced scientists
the University of Regensburg is particularly committed to support the reconciliation of work and family life. For more information please refer to https://www.uni-regensburg.de/equal-opportunities/chancengleichheit/startseite/index.html.